TORONTO and DALLAS, Dec. 3, 2024
/CNW/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK) (OTC:
PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical
technology company, wishes to notify shareholders that in case of
disruption due to the ongoing Canada Post strike, the Company's
meeting materials (the "Meeting Materials") for the Company's
upcoming annual general meeting to be held on December 12, 2024 at 1:00
p.m. (Toronto Time) (the "Meeting"), may be viewed on the
Company's SEDAR+ profile at www.sedarplus.ca and are also available
electronically on the Company's website at
www.perimetermed.com.
The Company has delivered the completed Meeting Materials to the
appropriate parties for mailing to registered and unregistered
shareholders prior to the Meeting. However, due to the postal
strike, it is possible that the Meeting Materials will not be
delivered to shareholders prior to the Meeting. Shareholders
will still be able to vote their shares either directly or by
proxy, or indirectly via their intermediary. Registered and
beneficial shareholders who have not received their Meeting
Materials, including the proxy, can direct requests for copies of
the Meeting Materials to Stephen
Kilmer, Investor Relations, at the contact details below.
The Company will provide copies of the Meeting Materials by email
to each shareholder who requests them while the strike is ongoing,
at no charge.
If you are a registered shareholder, please contact
Computershare Investor Services Inc. at 1-800-564-6253 (toll free
within North America) or
1-514-982-7555 to obtain your proxy form control number to
cast your vote for the upcoming Meeting.
If you hold shares through an intermediary such as a brokerage
firm, please contact your intermediary directly for a copy of the
proxy form and instructions for voting.
The Company's annual financial statements and related management
discussion and analysis, as well as interim financial statements
and related management discussion and analysis are available on the
Company's SEDAR+ profile and the Company's website as noted
above.
About Perimeter Medical Imaging AI, Inc.
Based in Toronto, Canada and
Dallas, Texas, Perimeter Medical
Imaging AI (TSX-V: PINK) (OTC: PYNKF) is a medical technology
company driven to transform cancer surgery with
ultra-high-resolution, real-time, advanced imaging tools to address
areas of high unmet medical need. Available across the U.S., our
FDA-cleared Perimeter S-Series OCT system provides real-time,
cross-sectional visualization of excised tissues at the cellular
level. The breakthrough-device-designated investigational Perimeter
B-Series OCT with ImgAssist AI represents our next-generation
artificial intelligence technology that is currently being
evaluated in a pivotal clinical trial, with support from a grant of
up to US$7.4 million awarded by the
Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a
reference to the pink ribbons used during Breast Cancer Awareness
Month.
Perimeter B-Series OCT is limited by U.S. law to
investigational use and not available for sale in the United States. Perimeter S-Series OCT has
510(k) clearance under a general indication and has not been
evaluated by the U.S. FDA specifically for use in breast tissue,
breast cancer, other types of cancer, margin evaluation, and
reducing re-excision rates. The safety and effectiveness of these
uses has not been established. For more information, please visit
www.perimetermed.com/disclosures.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in policies of the TSX Venture
Exchange) accepts responsibility for the adequacy or accuracy of
this release.
Forward-Looking Statements
This news release contains statements that constitute
"forward-looking information" within the meaning of applicable
Canadian securities legislation. In this news release, words such
as "may," "would," "could," "will," "likely," "believe," "expect,"
"anticipate," "intend," "plan," "estimate," and similar words and
the negative form thereof are used to identify forward-looking
statements. Forward-looking information may relate to management's
future outlook and anticipated events or results and may include
statements or information regarding the future financial position,
business strategy and strategic goals, competitive conditions,
research and development activities, projected costs and capital
expenditures, research and clinical testing outcomes, taxes and
plans and objectives of, or involving, Perimeter. Without
limitation, statements regarding the timing of the annual meeting,
are forward-looking information. Forward-looking statements should
not be read as guarantees of future performance or results, and
will not necessarily be accurate indications of whether, or the
times at or by which, any particular result will be achieved. No
assurance can be given that any events anticipated by the
forward-looking information will transpire or occur.
Forward-looking information is based on information available at
the time and/or management's good-faith belief with respect to
future events and are subject to known or unknown risks,
uncertainties, assumptions, and other unpredictable factors, many
of which are beyond Perimeter's control. Such forward-looking
statements reflect Perimeter's current view with respect to future
events, but are inherently subject to significant medical,
scientific, business, economic, competitive, political, and social
uncertainties and contingencies. In making forward-looking
statements, Perimeter may make various material assumptions,
including but not limited to (i) the accuracy of Perimeter's
financial projections; (ii) obtaining positive results from trials;
(iii) obtaining necessary regulatory approvals; and (iv) general
business, market, and economic conditions. Further risks,
uncertainties and assumptions include, but are not limited to,
those applicable to Perimeter and described in Perimeter's
Management Discussion and Analysis for the year ended December 31, 2023, which is available on
Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could
cause actual events or results to differ materially from those
projected in any forward-looking statements. Perimeter does not
intend, nor does Perimeter undertake any obligation, to update or
revise any forward-looking information contained in this news
release to reflect subsequent information, events, or circumstances
or otherwise, except if required by applicable laws.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/perimeter-provides-update-on-canada-postal-strike-and-mailing-of-the-companys-2024-annual-general-meeting-materials-302321559.html
SOURCE Perimeter Medical Imaging AI Inc.
